Navigating liver toxicity in the age of novel oncological agentsKey points
Summary: The advent of novel oncological therapies, including immune checkpoint inhibitors, antibody-drug conjugates, and protein kinase inhibitors, has revolutionised cancer treatment by significantly improving patient survival across a range of malignancies. However, these advances have been accom...
Saved in:
| Main Authors: | Mar Riveiro-Barciela, Eleonora De Martin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | JHEP Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S258955592500151X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatotoxicity evaluation of cannabidiol, cannabinol, cannabichromene and cannabigerol using a human quad culture liver chip
by: Jacob D. Larson, et al.
Published: (2025-08-01) -
Cholestatic Hepatic Injury Induced by Carbimazole: A Case Report and a Thorough Literature Review
by: Bassem Al Hariri, et al.
Published: (2025-06-01) -
Drug-induced liver injury in cancer patients
by: V. T. Ivashkin, et al.
Published: (2020-10-01) -
Semaglutide‐Induced Hepatic Injury: A Rare Case of Drug Induced Liver Injury
by: Rupayan Kundu, et al.
Published: (2025-08-01) -
Drug-induced liver injury. Part I: Classification, diagnosis and treatment
by: Dorota M. Kozielewicz, et al.
Published: (2025-03-01)